The impact of changes in matrix turnover on disease processes is gradually becoming more widely understood and appreciated. Similarly, the importance of interactions between the cellular and acellular components of any given tissue is finally being realized. An unhealthy cell does not make a healthy matrix; likewise an unhealthy matrix often leads to the demise of the cells within it, or at the very least to major changes in cell phenotype. We can therefore no longer investigate these two components in isolation, because the matrix so often contributes to cellular signalling pathways, and these in turn can lead to changes in matrix turnover. This is a long way from the traditional view of the role of the extracellular matrix, or 'ground substance', in filling the spaces between the cells and providing physical support for them. Just over 100 delegates assembled at Sheffield Hallam University for the Joint BSMB (British Society for Matrix Biology)/Biochemical Society Focused Meeting on Matrix Turnover: Mechanisms and Common Denominators on 2-3 April 2007. The stated aim of the meeting was to aid and encourage interactions between scientists working in various areas of matrix biology, and to this end there were sessions on intervertebral disc, turnover in the CNS (central nervous system), fibroses and tumour-stroma interactions, as well as a session covering general topics. The involvement of both the BSMB and Biochemical Society membership increased the potential for interactions between scientists and hopefully increased the value of the meeting for all the delegates. This issue of Biochemical Society Transactions contains papers written by those who gave oral presentations at the meeting. I think it is fair to conclude from their talks and the papers presented here that the 'common denominators' involved in matrix turnover include cytokine and growth factor signalling pathways that control the rates of matrix synthesis and breakdown, and which, in many disease processes, lead to an uncoupling of synthesis and breakdown and thereby the loss of homoeostasis. Evidently, the make-up of the matrix surrounding cells profoundly affects cell phenotype and behaviour through various signalling pathways. Numerous environmental stimuli may trigger these events, and a host of genes are undoubtedly involved in generating predisposing genotypes. Such factors appear to be common to many diseases involving matrix turnover.
measured in years [1] , whereas in the developing rat brain, it is less than 24 h [2] . Despite the enormous differences that exist in the rate of turnover, the main common denominator of normal matrix turnover in all situations is the exquisite degree of control exerted, so that just the exact amount of the correct matrix component at the right location is broken down and/or synthesized. Of course, the word given for this process is 'homoeostasis', but just because we can label the process, it does not mean that we fully understand it. The degree of control that is required to make, for example, a complete new organism during development, or to retain bone structure and calcium homoeostasis in the adult, is truly remarkable and is an absolute requirement in the evolution of complex organisms. We can learn a great deal about the molecular mechanisms of the homoeostatic control of matrix turnover by studying situations where it goes wrong, and many disease processes are characterized by an uncoupling of matrix synthesis and breakdown, so that too much matrix, or too little, is either laid down or broken down.
Fibrotic diseases are characterized by the manufacture and retention of too much extracellular matrix. This can seriously influence organ function, particularly in situations where the movement of metabolites or fluids is involved, such as in the lung, kidney or vascular system. Fibroses are also often characterized by the manufacture of inappropriate matrix components, replacing functional liver tissue with a scar, for instance. It seems clear that major players in the process of fibrosis are members of the TGF (transforming growth factor) superfamily of cytokines, particularly TGFβ which can orchestrate a complex downstream fibrotic response in fibroblasts [3] . But what are the factors leading to inappropriate activation of TGFβ? In this issue of Biochemical Society Transactions, Laurent et al. [4] (pp. 647-651) explore this question in some detail, including fibroblast phenotype, inflammatory mediators and mechanosensing and epithelial-mesenchymal cell transition and plasticity.
It is well known that mediators of inflammatory responses [for example, the cytokine IL-1 (interleukin 1)] may cause increased matrix breakdown. In diseases such as rheumatoid arthritis, this leads to loss of cartilage and bone, causing joint dysfunction [5, 6] . However, inflammation is often the initial cue in the subsequent development of a fibrosis, in pathologies as diverse as idiopathic pulmonary fibrosis and hypertrophic scar formation. The role played by an initial inflammatory event is not entirely clear, although activation of TGFβ and resulting downstream pathways may once again have a major impact. But the question of what decides whether an inflammatory response leads to matrix loss or fibrosis (or a healthy resolution) remains unanswered. Gauldie et al. [7] (pp. 661-664) notes that a fibrotic response can spread through an organ, away from the site of initial challenge, but does not cross tissue boundaries. Results from experiments using adenoviral gene transfer of IL-1β or TGF-β1 into the rodent lung suggest that the spread of the fibrotic response is due to autocrine effects of TGFβ, leading to the synthesis of this and other growth factors which then bind to the surrounding matrix and subsequently become available to other, neighbouring, cells. Such a process can be expedited by an underlying chronic inflammation that may increase the expression of proteolytic enzymes required to mobilize growth factors from the matrix.
Quality as well as quantity
Homoeostatic control of matrix turnover extends beyond mere control of matrix quantity. Obviously the composition of the matrix affects its mechanical properties as well the cells' behaviour within it. The complexity of post-translational modifications can be of enormous importance in this respect. We are all aware of the functions of covalent cross-links in the properties of interstitial collagens, and how these may vary depending on the source and age of the tissue. The impact of tissue transglutaminases on the breakdown of fibrotic tissues is an area under current study [8] . There are other modifications about which we are only now becoming aware. Tony Day and co-workers have been exploring the functions of TSG-6 (tumour necrosis factor-stimulated gene 6) in HA (hyaluronan)-rich tissues, and the functions of HA cross-linking in events such as cumulus expansion in ovulation [9] (pp. 672-676). HA is cross-linked via the heavy chains of inter-α-inhibitor, and Day and colleagues have now demonstrated that this cross-linking process is mediated through the action of TSG-6, which acts as a catalyst in this process [9] . The advent of tissue engineering has produced some interesting models that are only now beginning to be exploited in terms of comparing matrix composition with properties. Plainfossé et al. [10] (pp. 677-679) describe an interesting example where tissue-engineered cartilage is subjected to friction testing. Our ability to manufacture tissues in vitro will enable us to explore the correlations between composition and properties in much more detail.
Our capacity to formulate a CNS (central nervous system) in vitro is still extremely limited. Even so, it is clear that the matrix of the CNS plays fundamental roles in many aspects of its functions and maintenance. Uwe Rauch [11] (pp. 656-660) explained that proteoglycans are prominent in this matrix, but, in the absence of a cross-linked collagen scaffold to hold them in place, other mechanisms are required. As in cartilage, the proteoglycans of the CNS, such as aggrecan, neurocan and brevican, are non-covalently attached via their N-terminal domain to members of the Link protein family, which stabilizes the interaction with HA. The oligomeric tenascins also bind to the protoglycans, in this case to their C-terminal domains. Tenascins may also provide important connections with the cells, possibly through the cell adhesion molecule contactin-1 [11] or via integrins in wound healing [12] (pp. 695-697). It appears that the concentration of proteoglycans in the matrix is not controlled by their rate of synthesis, but rather by the availability of binding sites in the matrix [11] , and that unbound molecules are lost from the matrix. Such a scenario allows for the rapid turnover of proteoglycans [13] (pp. 692-694) without any loss in proteoglycan content. It thus seems that the maintenance of a constant proteoglycan content in the CNS may be very important. This view is strengthened further by the observation that, in mice lacking tenascin expression, these molecules are replaced by fibulins [14] which also bind to and retain the proteoglycans.
Controlling cell phenotype
It is now commonly understood that the extracellular matrix functions to control the phenotype of the cells within it, a process mediated by a plethora of cell-surface signalling receptors. Despite this knowledge, the growth of cells on plastic is still the mainstay of cell and cancer biology. Paraic Kenny et al. [15] (pp. 665-668) have provided a wonderful example of what can be learnt from the culture of cells within a matrix. Breast cancer cell lines of varying malignancy exhibit profoundly different phenotypes when grown in three-dimensions in an extracellular (basement membranelike) matrix. Non-malignant cells underwent a few rounds of cell division before forming a growth-arrested colony resembling a breast acinus. In contrast, malignant cells formed disorganized continuously proliferating colonies. This threedimensional model served to rapidly distinguish malignant from non-malignant cells and also provided opportunities for dissecting the molecular basis for malignant growth [15] .
Cellular scissors
Matrix breakdown is almost invariably mediated by proteolytic enzymes whose actions are inhibited by selective protein inhibitors. It is therefore not surprising that mediators of matrix breakdown stimulate proteinase action [16] , or that TGFβ stimulates synthesis of a proteinase inhibitor [17] . MMPs (matrix metalloproteinases) have for many years been intimately connected with matrix breakdown and as such are a target for the pharmaceutical industry [18] (pp. 689-691). In tuberculosis, the secretion of MMP-9 is up-regulated in the CNS as a downstream event leading from cell infection and altered astrocyte-leucocyte interactions [19] (pp. 686-688). MMP-9 may then be a major player in the widespread tissue destruction which is a hallmark of this disease. MT1-MMP (membrane type 1 MMP) supplies a link between the extracellular and intracellular pathways of matrix breakdown, providing the initial fragmentation of crosslinked collagen fibrils [20] (pp. 704-706) that allows internalization and breakdown by the lysosomal apparatus [21] . Judith Hoyland and collaborators have identified a role for the MMPs in intervertebral disc degeneration [22] . More recently, the expression profile of the 'aggrecanases', members of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) group of metalloproteinases, has been elucidated in intervertebral disc tissue. The expression of ADAMTS-1, -4, -5, -9 and -15 is increased in degeneration, whereas the expression of their inhibitor, TIMP-3 (tissue inhibitor of metalloproteinases-3), is not [23] (pp. 652-655).
This provides yet another example of loss of homoeostatic control in pathological matrix turnover.
It is now established that proteolytic enzymes can alter matrix turnover and composition in more subtle ways. For instance, proteolysis of tenascin-C releases fragments that inhibit fibroblast migration from this molecule which, when intact, stimulates migration. In this way, proteolysis may limit fibroblast infiltration into a wound bed. Conversely, lack of proteolytic activity in a fibrotic condition may add to the pathology by increasing the number of fibroblasts and hence the amount of matrix synthesized by the cells [12] . The serine proteinase HtrA1 is implicated in a number of disease processes and may also be a tumour suppressor. Its exact mechanisms of action have not been fully elucidated, but may be linked to its ability to degrade a number of matrix components and to its antagonistic interaction with members of the TGFβ superfamily. Canfield et al. [24] (pp. 669-671) have recently demonstrated that this enzyme also controls matrix mineralization, possibly through its inhibitory effect on the action of the TGF superfamily members BMPs (bone morphogenetic proteins). Cathepsin K is a cysteine proteinase which is expressed by osteoclasts and is involved in the turnover of the non-mineral component of bone, predominantly collagen I. Its action leads to the release of growth factors sequestered in the bone, and these are thought to contribute to the successful colonization of bone by prostate cancer metastases. However, collagen I is not the only substrate for this avid proteinase, and cleavage in bone of regulatory molecules such as osteonectin, SPARC (secreted protein acidic and rich in cysteine), VEGF (vascular endothelial growth factor), adiponectin, stromal-cell-derived factor 1 (SDF-1) and SCF (stem cell factor) may all contribute to the ability of bone to support metastatic cancer cells [25] (pp. 701-703).
Our understanding of the factors and processes controlling matrix turnover are bound to increase. However, the intricacy of interactions between growth factors, cytokines, receptors, proteolytic enzymes and matrix components themselves, in addition to the added complexity of a host of post-translational modifications that can differentially affect molecular localization and action, represents a real challenge for the future. Perhaps the greatest challenge of all will lie in the discovery of as yet unforeseen players in this process. I am sure many surprises lie ahead.
